Trent:₹3,256.10+30.96 (+0.96%)
Reliance Industries:₹1,377.50+1.93 (+0.14%)
Adani Ports:₹1,917.00-0.19 (-0.01%)
Tata Consumer:₹1,155.90+11.90 (+1.04%)
Titan Company:₹4,620.00-79.90 (-1.70%)
TCS:₹2,376.20+33.50 (+1.43%)
Trent:₹3,256.10+30.96 (+0.96%)
Reliance Industries:₹1,377.50+1.93 (+0.14%)
Adani Ports:₹1,917.00-0.19 (-0.01%)
Tata Consumer:₹1,155.90+11.90 (+1.04%)
Titan Company:₹4,620.00-79.90 (-1.70%)
TCS:₹2,376.20+33.50 (+1.43%)
Refer & Earn
Arihant Plus App

Arihant Plus App

Lincoln Pharmaceuticals Ltd

Lincoln Pharma. | 531633

Market Closed
₹511.90
₹0.15 (-0.03%)
As on 22/11/26, 6:56 PM
Market Cap1,025.62 CR
Current Price₹511.9
High / Low₹770 / 440
PE Ratio12.86
Book Value₹378.25
Dividend Yield0.00%
ROCE16.11%
ROE12.30%
Face Value₹2.00
Current Vol.14,236
Average Vol.---
ISININE405C01035
PB Ratio1.49
Debt to Equity0
Net Profit Margin13.1
Operating Margin19.54

LINCOLN - Share Price Chart

+₹0.00 (+0.00%)6M

Stock Performance

₹512.05₹510
₹511.9
Previous CloseToday's Open
₹440₹770
₹511.9
52W Low52W High
₹510Today's Open
₹512.05Previous Close
14,236Volume
₹44052W Low
₹77052W High

Ratios

No data available

About Company

  • Lincoln Pharmaceuticals Limited, was originally registered and formed as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations
  • The Firm was converted into a Public Company in January 1995 named 'Lincoln Pharmaceuticals Limited'
  • All the assets and business of the erstwhile partnership were transferred to the Company
  • The Company is engaged in the business of manufacturing and trading of pharmaceutical products
  • The focused area includes anti-infective, respiratory system, gynecology, cardio & CNS, anti-diabetic, anti malaria, among others
  • The Company was initially carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982
  • It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments
  • The company has set up a modern formulation manufacturing plant at Khatraj (Mehsana district), Gujarat, to manufacture small volume parenterals like dry powder injectables, liquid vial, liquid ampoules and eye drops and expand its production capacities of the existing products
  • It is also in the process of establishing a fully equipped laboratory to undertake in-house testing of its products for better quality control and R&D
  • It came out with a public issue in Feb

Research Calls

Research Calls
Locked Access

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI40.92
SMA 20518.54
SMA 50552.44
SMA 100579.22
SMA 200596.91
SMA 10517.71
MACD_12_26_Days-9.45
EMA10Day516.31
EMA20Day521.75
EMA50Day545.16
MACD_12_26_9_Days2.28
EMA100Day567.32
EMA200Day579.13

Pivot Points

Volume Analysis

Delivery
Total Volume

Growth Rate

Revenue Growth7.67%
ROE12.30%
EBITDA Margin19.54%

All figures in ₹ Crores

Indicators20262025202420232022
Revenue
671.03
623.23
580.55
510.31
472.12
Interest
1.01
1.88
1.46
2.03
1.45
Expenses
573.35
521.74
480.64
421.11
376.64
Financing Profit
131.14
123.97
134.33
111.68
105.48
Financing Margin %
20%
20%
23%
22%
22%
Other Income
33.45
22.48
34.42
22.47
10.00
Depreciation
14.50
12.90
10.62
9.17
8.09
Profit before tax
115.63
109.19
122.24
100.48
95.94
Tax %
24%
25%
24%
27%
28%
Net Profit
87.89
82.35
93.30
72.90
69.35
EPS in Rs
43.88
41.11
46.58
36.40
34.63
Show % Change
ShareHolding
📊

No Information Available

No shareholding data available at this time.

📊

No Data Available

No Block Deals data available for this company.

News

📊

No Information Available

No news available for this company.
Record Date
Corporate Action
Information
Announcement Day
30 Sept 2026
AGM
AGM
26 Aug 2026
11 Sept 2026
Final Dividend (₹1.8)
Recommended a Final Dividend of Rs. 1.80/- (i.e 18%) per equity share of face value Rs. 10/- each for the financial year ended March 31, 2026 subject to approval of the members at the ensuing Annual General Meeting of the Company. Newspaper Advertisement regarding the 32nd Annual General Meeting of the Company to be held on Wednesday, September 30, 2026. (As Per BSE Announcement Dated on 26.08.2026)
28 May 2026
30 Sept 2025
AGM
AGM
29 Aug 2025
12 Sept 2025
Final Dividend (₹1.8)
Recommended a Final Dividend of Rs. 1.80/- (i.e 18%) per equity shares of face value 10/- each for the Financial year Ended 31st March, 2025 subject to approval of the members at the ensuing A.G.M of the Company. The Intimation of Book Closure and Record Date is as enclosed. (As Per BSE Announcement Dated on: 29/08/2025)
22 May 2025
30 Sept 2024
AGM
AGM
02 Sept 2024
14 Sept 2024
Final Dividend (₹1.8)
Outcome of Audited Financial Results for Quarter and year Ended on 31st March, 2024
16 May 2024
30 Sept 2023
AGM
AGM
26 Aug 2023
16 Sept 2023
Final Dividend (₹1.5)
Recommended a dividend of 1.50/- (i.e. 15% per share) per equity share of face value of 10/- for the year ended March 31, 2023, for approval of the members at the ensuring annual general meeting (AGM) of the Company
25 May 2023
30 Sept 2022
AGM
AGM
26 Aug 2022
17 Sept 2022
Final Dividend (₹1.5)
Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 19, 2022, inter alia, has recommended a dividend of Rs. 1.50/- (i.e. 15% per share} per equity share of face value of Rs. 10/- for the year ended March 31, 2022, for approval of the members at the ensuring annual general meeting (AGM) of the Company.
19 May 2022

Peers

LTP(₹)
Market Cap(₹ Cr.)
P/E Ratio(Ratio)
P/B Ratio(Ratio)
Cash Earnings(Ratio)
Debt to Equity(Ratio)
Net Profit Ratio(%)
511
1,024
11
1
9
0
13.10%
1,885
4,52,299
37
5
30
0
19.78%
11,200
2,97,325
87
17
76
0
24.32%
4,699
1,78,727
82
10
44
1
11.09%
2,295
1,24,002
93
20
68
1
13.06%
1,195
1,19,207
26
4
18
0
9.82%
1,391
1,16,145
41
3
24
0
12.34%
1,415
1,14,312
37
3
26
0
9.92%
2,660
1,09,870
47
6
34
0
13.57%
1,795
1,03,298
25
3
17
0
10.41%
Showing 10 of 140 Results

Frequently Asked Questions

What is Share Price of Lincoln Pharmaceuticals Ltd?

The current share price of Lincoln Pharmaceuticals Ltd (Lincoln Pharma.) is ₹511.90. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Lincoln Pharmaceuticals Ltd?

The Price-to-Earnings (P/E) ratio of Lincoln Pharmaceuticals Ltd is 10.58. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Lincoln Pharmaceuticals Ltd?

Lincoln Pharmaceuticals Ltd has a 52-week high of ₹770.00 and a 52-week low of ₹440.00. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Lincoln Pharmaceuticals Ltd?

Lincoln Pharmaceuticals Ltd offers a dividend yield of 0.35%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Lincoln Pharmaceuticals Ltd?

The Earnings Per Share (EPS) of Lincoln Pharmaceuticals Ltd is ₹48.38. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Lincoln Pharmaceuticals Ltd?

Lincoln Pharmaceuticals Ltd has a Return on Equity (ROE) of 12.30%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

mobile

Ready to invest smarter?
Download the app today.

GET IT ON

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

DOWNLOAD ON THE

App Store

4.2